Evaluation of Carbohydrates - Glycemic Index
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03508154 |
|
Recruitment Status :
Completed
First Posted : April 25, 2018
Last Update Posted : May 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Glycemic Index | Other: Control Meal 1 Other: Control Meal 2 Other: Experimental Nutritional Product | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 10 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Evaluation of Carbohydrates: Glycemic Index of Nutrition Product Formulation |
| Actual Study Start Date : | May 7, 2018 |
| Actual Primary Completion Date : | May 22, 2018 |
| Actual Study Completion Date : | May 22, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Control Meal 1
Control carbohydrate solution
|
Other: Control Meal 1
carbohydrate test meal |
|
Active Comparator: Control Meal 2
Control carbohydrate solution
|
Other: Control Meal 2
carbohydrate test meal |
|
Experimental: Experimental Nutritional Product
Study nutritional formulation
|
Other: Experimental Nutritional Product
ready to drink nutritional formulation |
- Blood glucose response curve [ Time Frame: 0 to 120 minutes ]area under the curve
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subjects are males or non-pregnant females in good health
- Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion Criteria:
- Subjects with any type of food allergy or known history of AIDS, hepatitis, diabetes or a heart condition
- Subjects taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03508154
| Canada, Ontario | |
| Glycemic Index Laboratories Inc. | |
| Toronto, Ontario, Canada, M5C 2N8 | |
| Study Chair: | Anne Dumas | Abbott Nutrition |
| Responsible Party: | Abbott Nutrition |
| ClinicalTrials.gov Identifier: | NCT03508154 |
| Other Study ID Numbers: |
DA19 |
| First Posted: | April 25, 2018 Key Record Dates |
| Last Update Posted: | May 30, 2018 |
| Last Verified: | May 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

